GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » DA32 Life Science Tech Acquisition Corp (NAS:DALS) » Definitions » YoY Rev. per Sh. Growth

DA32 Life Science Tech Acquisition (DA32 Life Science Tech Acquisition) YoY Rev. per Sh. Growth : 0.00% (As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is DA32 Life Science Tech Acquisition YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. DA32 Life Science Tech Acquisition's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2023 was 0.00%.

DA32 Life Science Tech Acquisition's Revenue per Share for the three months ended in Mar. 2023 was $0.00.

DA32 Life Science Tech Acquisition YoY Rev. per Sh. Growth Historical Data

The historical data trend for DA32 Life Science Tech Acquisition's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DA32 Life Science Tech Acquisition YoY Rev. per Sh. Growth Chart

DA32 Life Science Tech Acquisition Annual Data
Trend Dec21 Dec22
YoY Rev. per Sh. Growth
- -

DA32 Life Science Tech Acquisition Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial - - - - -

DA32 Life Science Tech Acquisition YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

DA32 Life Science Tech Acquisition's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2022 )
=(Revenue per Share (A: Dec. 2022 )-Revenue per Share (A: Dec. 2021 ))/ | Revenue per Share (A: Dec. 2021 ) |
=(0-0)/ | 0 |
=N/A %

DA32 Life Science Tech Acquisition's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2023 )
=(Revenue per Share (Q: Mar. 2023 )-Revenue per Share (Q: Mar. 2022 )) / | Revenue per Share (Q: Mar. 2022 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DA32 Life Science Tech Acquisition YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of DA32 Life Science Tech Acquisition's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

DA32 Life Science Tech Acquisition (DA32 Life Science Tech Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » DA32 Life Science Tech Acquisition Corp (NAS:DALS) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
GTAC FHLT SHAP QFTA SRSA PRLH CRZN TCAC OPA VHNA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
345 Park Avenue South, 12th Floor, New York, NY, USA, 10010
Website
DA32 Life Science Tech Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Da32 Sponsor Llc 10 percent owner 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Management Company, L.p. (series C) director, 10 percent owner, other: Director by deputization 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Arch Venture Fund Xi, L.p. 10 percent owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631
Section 32 Fund 3, Lp 10 percent owner, other: Director by Deputization 169 UNIVERSITY AVE., PALO ALTO CA 94301
Keith Crandell director, 10 percent owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631
William J Maris 10 percent owner, other: Director by Deputization 2033 SAN ELIJO AVE., #565, CARDIFF-BY-THE-SEA CA 92007
Angela Lai director 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Arch Venture Partners Xi, Llc 10 percent owner 8755 W HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631
Arch Venture Partners Xi, L.p. 10 percent owner 8755 W HIGGINS RD., SUITE 1025, CHICAGO IL 60631
Section 32 Gp 3, Llc 10 percent owner, other: Director by Deputization 171 MAIN STREET, #671, LOS ALTOS CA 94022
Steven J. Kafka director, officer: Chief Executive Officer C/O FOUNDATION MEDICINE, INC., ONE KENDALL SQUARE, SUITE B3501, CAMBRIDGE MA 02139
Andrew Elbardissi director 2210 FARADAY AVE #100, CARLSBAD CA 92008
Chris Wolfe officer: Chief Financial Officer 230 PARK AVENUE SOUTH, 11TH FLOOR, C/O CAPITAL Z PARTNERS, NEW YORK NY 10003
Kristina Burow 10 percent owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631
Mara G. Aspinall director 7381 NORTH MOON SPIRIT LANE, TUCSON AZ 85718